Reducing drug related mortality in Europe - A seemingly intractable public health issue;Reducir la mortalidad relacionada con las drogas en Europa parece una cuestión de salud pública irresoluble

Adicciones

Volumn 24, Issue 1, 2012, Pages 3-7

  Giraudon, Isabelle ^a   Vicente, Julian ^a   Matias, João ^a   Mounteney, Jane ^a   Griffiths, Paul ^a  

^a EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

Author keywords

Drug users; Europe; HIV; Mortality; Overdose

Indexed keywords

ADDICTION; EDITORIAL; EUROPE; HUMAN; MORTALITY; PUBLIC HEALTH;

EUROPE; HUMANS; PUBLIC HEALTH; SUBSTANCE-RELATED DISORDERS;

EID: 84857875355     PISSN: 02144840     EISSN: None     Source Type: Journal    
DOI: 10.20882/adicciones.111     Document Type: Editorial

References (20)

1. Bargagli, A. M., Davoli, M., Minozzi, S., Vecchi, S., & Perucci, C. A. (2007). A Systematic Review of Observational Studies on Treatment of Opioid Dependence Geneva, Switzerland, WHO. Retrieved from: http://www.who.int/substance_abuse/activities/observational_studies_treatment.pdf
2. Bargagli, A. M., Hickman, M., Davoli, M., Perucci, C. A., Schifano, P., Buster, M. et al. (2006). Drug-related mortality and its impact on adult mortality in eight European countries. European Journal of Public Health, 16, 198-202. doi:10.1093/eurpub/cki168
3. Brugal, M. T., Domingo-Salvany, A., Puig, R., Barrio, G., Garcia de, O. P., & de la Fuente, L. (2005). Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction, 100, 981-989. doi:10.1111/j.1360-0443.2005.01089.x
4. Clausen, T., Anchersen, K., & Waal, H. (2008). Mortality prior to, during and after opioid maintenance treatment (OMT): a national prospective cross-registry study. Drug and Alcohol Dependence., 94, 151-157. doi:10.1016/j.drugalcdep.2007.11.003
5. Clausen, T., Waal, H., Thoresen, M., & Gossop, M. (2009). Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction, 104, 1356-1362. doi:10.1111/j.1360-0443.2009.02570.x
6. Cornish, R., Macleod, J., Strang, J., Vickerman, P., & Hickman, M. (2010). Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database. British Medical Journal, (7779), 928. doi:10.1136/bmj.c5475
7. Darke S, Degenhardt, L., & Mattick, R. (2007). Mortality amongst illicit drug users: epidemiology, causes and interventions Cambridge University Press.
8. Darke, S., Williamson, A., Ross, J., & Teesson, M. (2005). Non-fatal heroin overdose, treatment exposure and client characteristics: findings from the Australian treatment outcome study (ATOS). Drug and Alcohol Review, 24, 425-432. doi:10.1080/09595230500286005
9. Davoli, M., Bargagli, A. M., Perucci, C. A., Schifano, P., Belleudi, V., Hickman, M. VEdeTTE Study Group (2007). Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction, 102, 1954-1959. doi:10.1111/j.1360-0443.2007.02025.x
10. Degenhardt, L., Bucello, C., Mathers, B., Briegleb, C., Ali, H., Hickman, M. & McLaren, J. (2011a). Mortality among regular or dependent users of heroin and other opioids: a systematic review and metaanalysis of cohort studies. Addiction, 106, 32-51. doi:10.1111/j.1360-0443.2010.03140.x
11. Degenhardt, L., Randall, D., Hall, W., Law, M., Butler, T., & Burns, L. (2009). Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: risk factors and lives saved. Drug and Alcohol Dependendence, 105, 9-15. doi:10.1016/j.drugalcdep.2009.05.021
12. Degenhardt, L., Singleton, J., Calabria, B., McLaren, J., Kerr, T., Mehta, S., Hall, W.D. (2011b). Mortality among cocaine users: a systematic review of cohort studies. Drug and Alcohol Dependence, 113, 88-95. doi:10.1016/j.drugalcdep.2010.07.026
13. EMCDDA. (2011a). Mortality related to drug use in Europe: public health implications Luxembourg: Publications Office of the European Union. Retrieved from: http://www.emcdda.europa.eu/publications/selected-issues/mortality
14. EMCDDA. (2011b). The state of the drugs problem in Europe. Annual report 2011 Luxembourg: Publications Office of the European Union. Retrieved from: http://www.emcdda.europa.eu/publications/annualreport/2011
15. EMCDDA, & ECDC. (2011). Joint ECDC and EMCDDA rapid risk assessment HIV in Injecting Drug Users in the EU, following a reported increase of cases in Romania and Greece. doi:10.2810/50417 Retrieved from: http://www.emcdda.europa.eu/html.cfm/index146510EN.html
16. Merrall, E. L., Kariminia, A., Binswanger, I. A., Hobbs, M. S., Farrell, M., Marsden, J, Bird, S. M. (2010). Meta-analysis of drug-related deaths soon after release from prison. Addiction, 105, 1545-1554. doi:10.1111/j.1360-0443.2010.02990.x
17. Stenbacka, M., Leifman, A., & Romelsjo, A. (2010). Mortality and cause of death among 1705 illicit drug users: a 37 year follow up. Drug and Alcohol Review, 29, 21-27. doi:10.1111/j.1465-3362.2009.00075.x
18. Talu, A., Rajaleid, K., Abel-Ollo, K., Ruutel, K., Rahu, M., Rhodes, T., Uusküla, A. (2010). HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention. International Journal of Drug Policy, 21, 56-63. doi:10.1016/j.drugpo.2009.02.007
19. Vicente, J., Giraudon, I., Matias, J., Hedrich, D., & Wiessing, L. (2009). Rebound of overdose mortality in the European Union 2003-2005: findings from the 2008 EMCDDA Annual Report. Euro. Surveill, 14(2).
20. WHO Regional Office for Europe. (2010). Prevention of acute drugrelated mortality in prison populations during the immediate postrelease period. Copenhagen: WHO Regional Office for Europe. Retrieved from: http://www.euro.who.int/en/what-we-publish/abstracts/prevention-of-acute-drug-related-mortality-in-prisonpopulations-during-the-immediate-post-release-period